Paul Workman (born 30 March 1952) is a British scientist noted for his work on the discovery and development of pharmaceutical agents in the field of

oncology Oncology is a branch of medicine that deals with the study, treatment, diagnosis and prevention of cancer. A medical professional who practices oncology is an ''oncologist''. The name's etymological origin is the Greek word ὄγκος (''� ...

. He i
President and CEO
of The Institute of Cancer Research In London.

Education and early life

Workman was born on 30 March 1952 in

Workington Workington is a coastal town and civil parish at the mouth of the River Derwent on the west coast in the Allerdale borough of Cumbria, England. The town was historically in Cumberland. At the 2011 census it had a population of 25,207. Locat ...

Cumbria Cumbria ( ) is a ceremonial and non-metropolitan county in North West England, bordering Scotland. The county and Cumbria County Council, its local government, came into existence in 1974 after the passage of the Local Government Act 1972. C ...

, England. He was educated at Workington County Grammar School, Cumbria, and completed his

BSc A Bachelor of Science (BS, BSc, SB, or ScB; from the Latin ') is a bachelor's degree awarded for programs that generally last three to five years. The first university to admit a student to the degree of Bachelor of Science was the University ...

degree in

Biochemistry Biochemistry or biological chemistry is the study of chemical processes within and relating to living organisms. A sub-discipline of both chemistry and biology, biochemistry may be divided into three fields: structural biology, enzymology and ...

at the

University of Leicester , mottoeng = So that they may have life , established = , type = public research university , endowment = £20.0 million , budget = £326 million , chancellor = David Willetts , vice_chancellor = Nishan Canagarajah , head_lab ...

and his PhD degree in Cancer Pharmacology at the

University of Leeds , mottoeng = And knowledge will be increased , established = 1831 – Leeds School of Medicine1874 – Yorkshire College of Science1884 - Yorkshire College1887 – affiliated to the federal Victoria University1904 – University of Leeds , ...

. He later received an Honorary DSc degree from the University of Leicester in 2009.

Career and research

The early part of his career (1976–90) was spent establishing and leading the Pharmacology and New Drug Development Laboratory at the Medical Research Council's Clinical Oncology Unit at the

University of Cambridge The University of Cambridge is a public collegiate research university in Cambridge, England. Founded in 1209 and granted a royal charter by Henry III in 1231, Cambridge is the world's third oldest surviving university and one of its most pr ...

, where he developed new treatments to exploit hypoxic cells in solid tumours and elucidated the enzymes involved in the activation of hypoxia-targeted drugs. In 1990 Workman spent a sabbatical period in the Department of Therapeutic Radiology, Stanford University and SRI International, California, USA where he continued his work on tumour hypoxia funded by a Fellowship from what was then the International Union Against Cancer. In 1991 Workman was appointed as a Cancer Research Campaign (CRC) Life Fellow, Professor of Experimental Cancer Therapy, University of Glasgow and Director of Laboratory Research in the CRC Department of Medical Oncology, CRC Beatson Laboratories, Glasgow. Here he extended his research on tumour hypoxia and molecular targeted therapies. Workman also continued his service for the European Organisation for Research and Treatment of Cancer (EORTC) as Chairman of the EORTC Pharmacology and Molecular Mechanisms Group. Member of EORTC Board and Council as Chairman of the EORTC New Drug Development Coordinating Committee. Workman joined the ICR in 1997 to develop its

Cancer Research UK Cancer Research UK (CRUK) is the world's largest independent cancer research organization. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and t ...

Cancer Therapeutics Unit. Overall, since 2005, the Cancer Therapeutic Unit has discovered 17 drug candidates, seven of which have progressed to the patient trial stage. Workman has attributed this record to "taking early academic risks, combining academic and pharmaceutical expertise, and implementing strong leadership and project management. Other contributing factors include running multiple projects on a competitive scale, establishing long-term financial support and – most important – selecting productive and timely industrial collaborations." Workman was appointed Deputy CEO of the ICR in March 2011. He was later elected as President and CEO in November 2014. Workman is currently working on drugs that block molecules essential for the growth and survival of

cancer cell Cancer cells are cells that divide continually, forming solid tumors or flooding the blood with abnormal cells. Cell division is a normal process used by the body for growth and repair. A parent cell divides to form two daughter cells, and these d ...

s, in particular, molecular chaperones such as

Hsp90 Hsp90 (heat shock protein 90) is a chaperone protein that assists other proteins to fold properly, stabilizes proteins against heat stress, and aids in protein degradation. It also stabilizes a number of proteins required for tumor growth, ...

. The leading Hsp90 inhibitor was discovered by Workman's team at ICR in collaboration with Vernalis.

Awards and honours

* 2010 elected

Fellow of the Royal Society of Chemistry Fellowship of the Royal Society of Chemistry (FRSC) is an award conferred by the Royal Society of Chemistry (RSC) in the United Kingdom. FRSC award Achieving Fellow status in the chemical profession denotes to the wider community a high level of ...

(FRSC) * 2010

Royal Society of Chemistry The Royal Society of Chemistry (RSC) is a learned society (professional association) in the United Kingdom with the goal of "advancing the chemical sciences". It was formed in 1980 from the amalgamation of the Chemical Society, the Royal Instit ...

George and Christine Sosnovsky Award in Cancer Therapy * 2014 awarded Raymond Bourgine Award for "exceptional contributions to oncology". * 2016 elected Fellow of the Royal Society (FRS)

References

{{DEFAULTSORT:Workman, Paul 1952 births Living people People from Workington Alumni of the University of Leicester Alumni of the University of Leeds English biologists English scientists Academics of the Institute of Cancer Research Academics of the University of Cambridge Fellows of the Academy of Medical Sciences (United Kingdom) Fellows of the Royal Society